4 unknown, 3 completed. 7 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 4, Completed 3 |
| Phase 2 | 4 | Unknown 3, Completed 1 |
Follow Urinary Incontinence, Urge: new trials by email Literature Review of Urinary Incontinence, Urge trials Research Report on Urinary Incontinence, Urge
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS Valacyclovir - Pain, Chronic, Urge Incontinence | Phase 1 | Unknown | Buddhist Tzu Chi General Hospital | 30 | 2021-07-01 | 2021-10-26 |
| Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa TOT, solifenacin - Surgical Treatment of Urge Incontinence | Phase 1 / Phase 2 | Unknown | Klinikum der Universität Köln | 120 | 2013-01-01 | 2015-04-07 |
| Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women solifenacin, cesa/vasa - Urge Urinary Incontinence | Phase 1 / Phase 2 | Unknown | Klinikum der Universität Köln | 120 | 2013-01-01 | 2015-04-07 |
| Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder Toviaz - Overactive Bladder | Phase 1 | Completed | University of Pennsylvania | 75 | 2011-05-01 | 2014-12-10 |
| Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence UISH001, matching placebo - Urinary Incontinence | Phase 1 / Phase 2 | Completed | Beech Tree Labs, Inc. | 94 | 2011-04-01 | 2013-05-03 |
| The Effect Of Fluconazole On Pharmacokinetics Of Fesoterodine In Healthy Subjects Fesoterodine, fesoterodine plus fluconazole - Overactive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary Incontinence | Phase 1 | Completed | Pfizer | 28 | 2009-05-01 | 2011-06-01 |
| Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence botulinum toxin type A - Urge Urinary Incontinence | Phase 1 / Phase 2 | Unknown | Glostrup University Hospital, Copenhagen | 20 | 2009-01-01 | 2009-08-04 |
Chronic Pain (1) · Urinary Bladder, Overactive (1) · Urinary Incontinence (1) · Urinary Incontinence, Stress (1)
Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Lower Urinary Tract Symptoms (7) · Male Urogenital Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Signs and Symptoms (7) · Urination Disorders (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Urological Manifestations (7) · Urinary Incontinence (6) · Neurologic Manifestations (1) · Pain (1) · Urinary Bladder Diseases (1)
Solifenacin Succinate (2) · fesoterodine (2) · Botulinum Toxins, Type A (1) · Fluconazole (1) · Valacyclovir (1)
Klinikum der Universität Köln (2) · Beech Tree Labs, Inc. (1) · Buddhist Tzu Chi General Hospital (1) · Glostrup University Hospital, Copenhagen (1) · Pfizer (1) · University of Pennsylvania (1)
United States (3) · Germany (2) · Denmark (1) · Taiwan (1)
Wolfram H Jager, PhD (2) · Lily A Arya, MS, MD (1)